These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17991181)

  • 1. Helicobacter pylori as a vaccine delivery system.
    Marshall B; Schoep T
    Helicobacter; 2007 Nov; 12 Suppl 2():75-9. PubMed ID: 17991181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in vaccine development against Helicobacter pylori.
    Svennerholm AM; Lundgren A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):146-56. PubMed ID: 17442014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN; Every AL; Edwards S; Sutton P
    Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
    Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
    Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the development of vaccines against Helicobacter pylori: status and issues.
    Del Giudice G
    Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against Helicobacter pylori.
    Del Giudice G; Malfertheiner P; Rappuoli R
    Expert Rev Vaccines; 2009 Aug; 8(8):1037-49. PubMed ID: 19627186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an attenuated Listeria monocytogenes as a vaccine vector to control Helicobacter pylori infection.
    Wang S; Ma J; Ji Q; Liu Q
    Immunol Lett; 2021 Oct; 238():68-74. PubMed ID: 34363896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori.
    Wehrens A; Aebischer T; Meyer TF; Walduck AK
    Helicobacter; 2008 Apr; 13(2):94-102. PubMed ID: 18321299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice].
    Lin HJ; Yang Q; Li J; Liu Y; Wang QY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):436-7. PubMed ID: 18359706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies.
    Wilson KT; Crabtree JE
    Gastroenterology; 2007 Jul; 133(1):288-308. PubMed ID: 17631150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development against Helicobacter pylori infections.
    Haas R; Meyer TF
    Biologicals; 1997 Jun; 25(2):175-7. PubMed ID: 9236048
    [No Abstract]   [Full Text] [Related]  

  • 16. Helicobacter pylori vaccine: from past to future.
    Agarwal K; Agarwal S
    Mayo Clin Proc; 2008 Feb; 83(2):169-75. PubMed ID: 18241627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.
    Skene CD; Doidge C; Sutton P
    Vaccine; 2008 Jul; 26(31):3880-4. PubMed ID: 18547687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.
    Rupnow MF; Chang AH; Shachter RD; Owens DK; Parsonnet J
    J Infect Dis; 2009 Oct; 200(8):1311-7. PubMed ID: 19751153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.